Paion AG
FSX:PA8.DE
Overview | Financials
Company Name | Paion AG |
Symbol | PA8.DE |
Currency | EUR |
Price | 0.36 |
Market Cap | 2,709,497 |
Dividend Yield | 0% |
52-week-range | 0.224 - 9.8 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Tilmann Bur |
Website | https://www.paion.com |
An error occurred while fetching data.
About Paion AG
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. It is also
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD